Home CannRx

CannRx

New Data Shows CannTrap Technology Optimizes Cannabis Product Effects

The data from a CannRx-sponsored pharmacokinetic animal study shows that using CannTrap with cannabis-derived products increases bioavailability up to 100 percent, while the normal bioavailability of cannabis is around 6 to 18 percent.